Lawyers say Bard's PowerPort devices, which pump intravenous chemotherapy and other fluids injected into the bloodstream, could generate up to 10,000 lawsuits.
July 03, 2023 at 05:04 AM
5 minute read
staff reporter
In 2019, the U.S. Food and Drug Administration discontinued a reporting program that for years collected confidential data from medical device manufacturers about problems with their products.
When that data later became public, lawyers uncovered a big issue with C.R. Bard Inc.’s PowerPort, a medical device, which is implanted under the skin to provide intravenous chemotherapy, nutrition and other fluids.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
